Showing results (501-510 of 878) with videos related to
Sort By:
Pageof 88
European Heart Journal|February 25, 2011
EuroHeart score for the evaluation of in-hospital mortality in patients undergoing percutaneous coronary interventionMaarten de Mulder, Anselm Gitt, Ron van Domburg, et al.Hematological Oncology|September 23, 2010
The duration of the use of imatinib mesylate is only weakly related to elevated BNP levels in chronic myeloid leukaemia patientsMilena S Marcolino, Eric Boersma, Nelma C D Clementino, et al.Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|September 22, 2009
Factors affecting sensitivity and specificity of diagnostic testing: dobutamine stress echocardiographyMarcel L Geleijnse, Boudewijn J Krenning, Bas M van Dalen, et al.Arquivos Brasileiros De Cardiologia|November 1, 2018
Adiponectin in Relation to Coronary Plaque Characteristics on Radiofrequency Intravascular Ultrasound and Cardiovascular OutcomeBárbara Campos Abreu Marino, Nermina Buljubasic, Martijn Akkerhuis, et al.Circulation|February 16, 2006
Effect of posterolateral scar tissue on clinical and echocardiographic improvement after cardiac resynchronization therapyGabe B Bleeker, Theodorus A M Kaandorp, Hildo J Lamb, et al.Heart (British Cardiac Society)|September 25, 2017
Prognostic value of galectin-3 in adults with congenital heart diseaseVivan J M Baggen, Annemien E van den Bosch, Jannet A Eindhoven, et al.Journal of the American Heart Association|March 28, 2018
Prognostic Value of Serial N-Terminal Pro-B-Type Natriuretic Peptide Measurements in Adults With Congenital Heart DiseaseVivan J M Baggen, Sara J Baart, Annemien E van den Bosch, et al.Circulation|September 6, 2007
Left ventricular resynchronization is mandatory for response to cardiac resynchronization therapy: analysis in patients with echocardiographic evidence of left ventricular dyssynchrony at baselineGabe B Bleeker, Sjoerd A Mollema, Eduard R Holman, et al.Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|March 18, 2016
Matrix metalloproteinases as candidate biomarkers in adults with congenital heart diseaseVivan J M Baggen, Jannet A Eindhoven, Annemien E van den Bosch, et al.European Journal of Hospital Pharmacy : Science and Practice|June 27, 2020
COvid MEdicaTion (COMET) study: protocol for a cohort studyRoos S G Sablerolles, Freija E F Hogenhuis, Melvin Lafeber, et al.Pageof 88